Table 1. Clinical Characteristics of Participants.
Table A: Children with dystonia. Subject ID; Sex [M: Male; F: Female]; Age [years]; Diagnosis; Deep Brain Stimulation (DBS) [Y: yes; N: no]; Severity of Right Arm (R Arm), Left Arm (L Arm), Trunk, and Total Score (scores are based on the Barry-Albright Dystonia Scale16; for each segment the score ranges from 0 - absence of dystonia - to 4 - severe dystonia); Dominant arm (Dom. Arm); Medications.
Table B: Control children. Subject ID; Sex; Age; Dominant arm.
| A) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| ID | SEX | AGE | DIAGNOSIS | DBS | BAD SCALE SCORE | DOM. ARM | MEDICATIONS | |||
| R Arm | L Arm | Trunk | Total | |||||||
| d1 | M | 16 | Secondary dystonia, Cerebral Palsy | N | 1 | 1 | 0 | 2 | L | No Medication |
| d2 | F | 15 | Primary dystonia, DYT1- | Y | 1 | 1 | 2 | 12 | R | Trihexyphenidyl |
| d3 | M | 11 | Secondary dystonia, Cerebral Palsy | N | 2 | 2 | 1 | 12 | R | Clonazepam |
| d4 | F | 19 | Generalized secondary dystonia | N | 3 | 3 | 0 | 10 | R | Carbidopa-Levodopa |
| d5 | M | 21 | Secondary dystonia, Traumatic Brain Injury (TBI) | N | 3 | 0 | 0 | 8 | R | No Medication |
| d6 | M | 16 | Generalized secondary dystonia | N | 1 | 1 | 0 | 3 | R | Trihexyphenidyl |
| d7 | M | 20 | Primary dystonia | N | 2 | 2 | 0 | 8 | R | Vitamine E, Botulinum toxin injection 3 months prior the study |
| d8 | M | 11 | Secondary dystonia, Cerebral Palsy | N | 3 | 3 | 2 | 14 | R | Trihexyphenidyl / Carbidopa-Levodopa |
| B) | |||
|---|---|---|---|
| ID | SEX | AGE | DOM. ARM |
| c1 | M | 17 | R |
| c2 | M | 15 | R |
| c3 | F | 10 | R |
| c4 | M | 19 | R |
| c5 | F | 21 | R |
| c6 | M | 17 | R |
| c7 | M | 15 | R |
| c8 | M | 11 | R |